These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15111005)

  • 1. Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
    Small DH
    Trends Neurosci; 2004 May; 27(5):245-9. PubMed ID: 15111005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of synaptic homeostasis in Alzheimer's disease.
    Small DH
    Curr Alzheimer Res; 2004 Feb; 1(1):27-32. PubMed ID: 15975082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences].
    Nieoullon A
    Psychol Neuropsychiatr Vieil; 2010 Jun; 8(2):123-31. PubMed ID: 20525543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors: A new class of psychotropic compounds.
    Cummings JL
    Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the pharmacotherapy of Alzheimer's disease.
    Gauthier S
    CMAJ; 2002 Mar; 166(5):616-23. PubMed ID: 11898943
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
    Van Beek AH; Claassen JA
    Behav Brain Res; 2011 Aug; 221(2):537-42. PubMed ID: 20060023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
    Shinagawa S; Shigeta M
    Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients.
    Sirviö J
    Gerontology; 1999; 45 Suppl 1():3-14. PubMed ID: 9876213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic function and Alzheimer's disease.
    Giacobini E
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of Alzheimer's disease].
    Sulkava R
    Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892
    [No Abstract]   [Full Text] [Related]  

  • 14. p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors.
    Correa-Basurto J; Alcántara IV; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2005 Jul; 40(7):732-5. PubMed ID: 15935907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H; Grossberg GT
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.
    Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI
    Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic strategies in the treatment of Alzheimer's disease.
    Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
    Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
    Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
    Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.